• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Pacific Growth Equities Announces 2006 Life Sciences Growth Conference

Posted on: Wednesday, 26 April 2006, 12:00 CDT

Pacific Growth Equities, an investment bank specializing in emerging growth companies, announced today it will host its annual Life Sciences Growth Conference on June 12-14 at the Inter-Continental Mark Hopkins Hotel in San Francisco. Institutional investors, venture capitalists and life sciences industry insiders will focus on and interact with senior management from over 170 leading public and private companies with the highest growth potential in the second half of 2006 and beyond.

"2006 is rewarding those investors with a detail oriented approach in the Life Sciences space," said Thomas J. Dietz, Ph.D., Co-Chief Executive Officer. "The Pacific Growth Equities Life Sciences Growth Conference continues to be the leading venue for knowledgeable investors to assess progress and portfolio strategy at mid-year. In this environment, we have found it is particularly important for companies and investors to have a positive forum that encourages interaction. Our annual conference provides a mixture of group and individual meetings designed to find that common ground. "

Please visit the conference website at www.pacificgrowth.com/conference/index.html to get continuous, up-to-date information on presenting companies, speakers and events.

The preliminary list of confirmed presenting companies includes:

 Acuity Pharmaceuticals (Private) Actelion (ATLN) Adolor (ADLR) Advancis Pharmaceutical (AVNC) ADVENTRX Pharmaceuticals (ANX) AEterna Zentaris (AEZS) Affymax (Private)Alexion Pharmaceuticals (ALXN) Alexza Pharmaceuticals (ALXA) Alkermes (ALKS) Alnylam Pharmaceuticals (ALNY) Anacor Pharmaceuticals (Private) Anadys Pharmaceuticals (ANDS) AnorMED (AOM) Archemix (Private) Arena Pharmaceuticals (ARNA) ArthroCare (ARTC) ARYx Therapeutics (Private) Aspreva Pharmaceuticals (ASPV) Astex Therapeutics (Private) Aviara Dx (Private) Avigen (AVGN) Barrier Therapeutics (BTRX) BioMarin Pharmaceutical (BMRN) BioMimetic Therapeutics (Private) BioXell (Private) BiPar Sciences (Private) Calypso Medical Technologies (Private) Cambridge Antibody Technology Group (CATG) CancerVax (CNVX) CardioPlus (Private) CBio (Private) Cellerant Therapeutics (Private) Cepheid (CPHD) Chelsea Therapeutics (CHTP) ChemGenex Pharmaceuticals (CXSP) China Medical Technologies (CMED) Cholestech (CTEC) Coley Pharmaceutical Group (COLY) CombinatoRx (CRXX) Corgentech (CGTK) CoTherix (CTRX) Critical Therapeutics (CRTX) Cubist Pharmaceuticals (CBST) CV Therapeutics (CVTX) Cytokinetics (CYTK) Cytori Therapeutics (CYTX) deCODE genetics (DCGN) Digirad (DRAD) Discovery Laboratories (DSCO) Dyax (DYAX) Dynavax Technologies (DVAX) Elixir Pharmaceuticals (Private) Encysive Pharmaceuticals (ENCY) Endo Pharmaceuticals (ENDP) Endologix (ELGX) EPIX Pharmaceuticals (EPIX) Esprit Pharma (Private) Exelixis (EXEL) FoldRx Pharmaceuticals (Private) Genmab A/S (GEN) Genomic Health (GHDX) GlobeImmune (Private) GPC Biotech AG (GPCB) Hana Biosciences (HBX) Hologic (HOLX) Human Genome Sciences (HGSI) Icagen (ICGN) Idenix Pharmaceuticals (IDIX) Ikaria (Private) Illumina (ILMN) Immunicon (IMMC) Incyte (INCY) Indevus Pharmaceuticals (IDEV) Infinity Pharmaceuticals (Private) Inflazyme Pharmaceuticals (IZP) Inhibitex (INHX) Inotek Pharmaceuticals (Private) Intarcia Therapeutics (Private) InterMune (ITMN) IRIDEX (IRIX) Isis Pharmaceuticals (ISIS) KAI Pharmaceuticals (Private) Kensey Nash (KNSY) Keryx Biopharmaceuticals (KERX) Koronis Pharmaceuticals (Private) Kos Pharmaceuticals (KOSP) Kosan Biosciences (KOSN) La Jolla Pharmaceutical (LJPC) Laserscope (LSCP) LifeCell (LIFC) Luminex (LMNX) MacroGenics (Private) Manhattan Pharmaceuticals (MHA) MannKind (MNKD) MediciNova (4875) Merrimack Pharmaceuticals (Private) Metabolic Pharmaceuticals (MBP) Microbia (Private) Momenta Pharmaceuticals (MNTA) Monogram Biosciences (MGRM) Natus Medical (BABY) Nektar Therapeutics (NKTR) Neuren Pharmaceuticals (NEU) Neurogen (NRGN) NeurogesX (Private) Neuromed Pharmaceuticals (Private) NeuroMetrix (NURO) NicOx S.A. (Eurolist: NICOX) NitroMed (NTMD) Novacea (Private) Novadaq Technologies (NDQ) NovaDel Pharma (NVD) Noven Pharmaceuticals (NOVN) Nuvelo (NUVO) OmniSonics Medical Technologies (Private) Onyx Pharmaceuticals (ONXX) OraSure Technologies (OSUR) OREXIGEN Therapeutics (Private) Orthovita (VITA) Panacos Pharmaceuticals (PANC) Paratek Pharmaceuticals (Private) PDL BioPharma (PDLI) Penwest Pharmaceuticals (PPCO) Peptimmune (Private) Pharmacyclics (PCYC) Pharmion (PHRM) Point Therapeutics (POTP) Portola Pharmaceuticals (Private) Progenics Pharmaceuticals (PGNX) Prometheus Laboratories (Private) QuatRx Pharmaceuticals (Private) Quidel (QDEL) Regeneration Technologies (RTIX) Reliant Pharmaceuticals (Private) Renovis (RNVS) Rigel Pharmaceuticals (RIGL) RITA Medical Systems (RITA) Salix Pharmaceuticals (SLXP) Savient Pharmaceuticals (SVNT) SGX Pharmaceuticals (SGXP) Solexa (SLXA) Somaxon Pharmaceuticals (SOMX) SonoSite (SONO) Sonus Pharmaceuticals (SNUS) Speedel (SPPN) STAAR Surgical (STAA) Stratagene (STGN) Sunesis Pharmaceuticals (SNSS) Surface Logix (Private) Targacept (TRGT) Telik (TELK) Tercica (TRCA) The Medicines Company (MDCO) Theravance (THRX) TorreyPines Therapeutics (Private) TransOral Pharmaceuticals (Private) Trigen Holdings AG (Private) Trimeris (TRMS) Valera Pharmaceuticals (VLRX) Varian Medical Systems (VAR) Vertex Pharmaceuticals (VRTX) Vital Images (VTAL) XDx (Private) XenoPort (XNPT) Xoft (Private) ZONARE Medical Systems (Private) ZymoGenetics (ZGEN) 

About Pacific Growth Equities, LLC

Pacific Growth Equities is an investment bank specializing in and focused on emerging growth companies. With offices in San Francisco and Boston, the Firm's principal areas of focus are within the life sciences and technology sectors as well as identifying special growth situations. Employee owned, Pacific Growth Equities offers a full range of investment banking and brokerage services including public equity offerings, private equity offerings, proprietary sell-side research, and M&A and strategic advisory services. For more information, please visit the website at www.pacificgrowthequities.com. Member NASD, SIPC.

 For more information please contact: Rich Horn 415-274-6869 Contact via http://www.marketwire.com/mw/emailprcntct?id=15E21455A09F5C7A  

SOURCE: Pacific Growth Equities, LLC

Source: MARKET WIRE

More News in this Category